{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:08:04Z","timestamp":1771949284391,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010253","name":"Secretar\u00eda de Ciencia y T\u00e9cnica, Universidad de Buenos Aires","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007351","name":"University of Buenos Aires Secretariat of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007351","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Argentina de Microbiolog\u00eda"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ram.2025.07.003","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T12:51:28Z","timestamp":1757335888000},"page":"36-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial resistance profiles in multidrug-resistant Pseudomonas aeruginosa isolates in a university hospital in Argentina. Activity of new antibiotic combinations"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0614-3056","authenticated-orcid":false,"given":"Carla","family":"Alvarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Vay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngela","family":"Famiglietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Nastro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hern\u00e1n","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ram.2025.07.003_bib0090","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ijantimicag.2018.07.027","article-title":"Loss of activity of ceftazidime\u2013avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis","volume":"52","author":"Chalhoub","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ram.2025.07.003_bib0095","series-title":"Performance standards for antimicrobial susceptibility testing; 34rd informational supplement","year":"2024"},{"key":"10.1016\/j.ram.2025.07.003_bib0100","series-title":"Breakpoint tables for interpretation of MICs and zone diameters. Version 13.1","year":"2023"},{"key":"10.1016\/j.ram.2025.07.003_bib0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/antibiotics13030285","article-title":"Antimicrobial and diagnostic stewardship of the novel \u03b2-lactam\/\u03b2-lactamase inhibitors for infections due to carbapenem-resistant Enterobacterales species and Pseudomonas aeruginosa","volume":"13","author":"Ferous","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ram.2025.07.003_bib0110","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3390\/antibiotics11081101","article-title":"Comparative in vitro activity of ceftolozane\/tazobactam against clinical isolates of Pseudomonas aeruginosa and Enterobacterales from five Latin American countries","volume":"11","author":"Garc\u00eda-Betancur","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ram.2025.07.003_bib0115","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00695-20","article-title":"Imipenem-relebactam susceptibility testing of gram-negative bacilli by agar dilution, disk diffusion, and gradient strip methods compared with broth microdilution","volume":"58","author":"Hakvoort","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ram.2025.07.003_bib0120","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00031-19","article-title":"Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections","volume":"32","author":"Horcajada","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ram.2025.07.003_bib0125","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00472-17","article-title":"In vitro activity of aztreonam\u2013avibactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated by clinical laboratories in 40 countries from 2012 to 2015","volume":"61","author":"Karlowsky","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ram.2025.07.003_bib0130","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10096-024-04994-6","article-title":"In-vitro activity of the novel \u03b2-lactam\/\u03b2-lactamase inhibitor combinations and cefiderocol against carbapenem-resistant Pseudomonas spp. clinical isolates collected in Switzerland in 2022","volume":"44","author":"Le Terrier","year":"2025","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ram.2025.07.003_bib0135","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3389\/fmicb.2018.00685","article-title":"The versatile mutational resistome of Pseudomonas aeruginosa","volume":"9","author":"L\u00f3pez-Causap\u00e9","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ram.2025.07.003_bib0140","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00210-21","article-title":"In vitro activity of the ultrabroad-spectrum beta-lactamase inhibitor QPX7728 in combination with multiple beta-lactam antibiotics against Pseudomonas aeruginosa","volume":"65","author":"Lomovskaya","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ram.2025.07.003_bib0145","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1035609","article-title":"Molecular mechanisms leading to ceftolozane\/tazobactam resistance in clinical isolates of Pseudomonas aeruginosa from five Latin American countries","volume":"13","author":"Mojica","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ram.2025.07.003_bib0150","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00651-22","article-title":"Molecular mechanisms of resistance to ceftazidime\/avibactam in clinical isolates of Enterobacterales and Pseudomonas aeruginosa in Latin American hospitals","volume":"8","author":"Mojica","year":"2023","journal-title":"mSphere"},{"key":"10.1016\/j.ram.2025.07.003_bib0155","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/cid\/ciac268","article-title":"Guidance on the treatment of extended-spectrum \u03b2-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa)","volume":"75","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ram.2025.07.003_bib0160","unstructured":"Servicio de Antimicrobianos. Instituto Nacional de Referencia Dr. Carlos G. Malbr\u00e1n. Vigilancia de la Resistencia a los Antimicrobianos. Red WHONET. Tendencias 2013-2023. Available from: http:\/\/antimicrobianos.com.ar\/wp-content\/uploads\/2024\/12\/Vigilancia-Nacional-de-la-Resistencia-a-los-Antimicrobianos-Red-WHONET-Argentina-Tendencias-2013-2023.pdf. [Last Accessed 18 March 2025]."},{"key":"10.1016\/j.ram.2025.07.003_bib0165","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ram.2025.07.003_bib0170","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00115-20","article-title":"New \u03b2-lactam\u2013\u03b2-lactamase inhibitor combinations","volume":"34","author":"Yahav","year":"2020","journal-title":"Clin Microbiol Rev"}],"container-title":["Revista Argentina de Microbiolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0325754125000872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0325754125000872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:45:03Z","timestamp":1771947903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0325754125000872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0325754125000872"],"URL":"https:\/\/doi.org\/10.1016\/j.ram.2025.07.003","relation":{},"ISSN":["0325-7541"],"issn-type":[{"value":"0325-7541","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial resistance profiles in multidrug-resistant Pseudomonas aeruginosa isolates in a university hospital in Argentina. Activity of new antibiotic combinations","name":"articletitle","label":"Article Title"},{"value":"Revista Argentina de Microbiolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ram.2025.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Asociaci\u00f3n Argentina de Microbiolog\u00eda.","name":"copyright","label":"Copyright"}]}}